The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +309.56% increase from the last price of 2.93.
The current consensus among 5 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.54
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.